Dyne Therapeutics DYN
NASDAQ DYN
$16.52 +0.25 (+1.54%)
As of: Oct 21, 2026 · 10:43 AM EDT

Dyne Therapeutics (DYN) Non-Current Debt (2020)

Updated

Dyne Therapeutics' Non-Current Debt came in at $9.94 million for Q3 2020.

Analysis

Dyne Therapeutics (DYN) Non-Current Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,131.65 Bn 1,100.24 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 615.89 Bn 534.41 Bn 17.26 Bn 37.34 Bn
3 AbbVie 505.03 Bn 478.14 Bn 12.70 Bn 62.48 Bn
4 Merck 368.78 Bn 323.16 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.66 Bn 262.65 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 262.09 Bn 235.78 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.57 Bn 191.97 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.05 Bn 165.25 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.60 Bn 117.25 Bn 10.94 Bn 60.50 Bn
10 Dyne Therapeutics 2.72 Bn -1.05 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 9.94 Mn
API Access

Dyne Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=DYN&period=max&api_key=YOUR_API_KEY